The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The North Carolina House of Representatives approved a budget plan on May 22 for the next two fiscal years that would cut ...

Many people avoid this conversation, hoping it will never become relevant. Yet, when a medical crisis strikes, the absence of ...